Piedmont Lithium Q1 2024 revenue $13.4M, net loss $23.6M; NAL record production, Carolina Lithium permit

Piedmont Lithium Inc.

2024-Q1 EPS reported -$1.22 revenue$13,401,000

Q1 revenue $13.4M on ~15,500 dmt spodumene concentrate; net loss $23.6M ($1.22 diluted EPS); adjusted net loss $11.9M ($0.61).
NAL record quarterly production 40,439 dmt; lithium recoveries 69% in March; full run-rate expected H2 2024.
Carolina Lithium mining permit received May 2024; accelerating funding discussions with strategic partners.
Cash $71.4M as of March 31, 2024; working capital nearly doubled from year-end 2023.
2024 outlook: full-year shipments ~126,000 dmt weighted to H2; H2 shipments to more than double H1; investments down >50% H2 vs H1.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Piedmont Lithium Inc. reported quarter ended March 31, 2024 results: revenue $13.4 million, net income ($23.6 million), EPS ($1.22) per diluted share.

Period: quarter ended March 31, 2024
Revenue: $13.4 million
Net income: ($23.6 million)
EPS: ($1.22) per diluted share
Result: reported results

Exact text from the filing

Revenue of $13.4 million on sales of approximately 15,500 dmt of spodumene concentrate • $71.4 million in cash as of March 31, 2024; working capital nearly doubled from 2023 year end • 2024 outlook for shipments to more than double and investments to decrease more than 50% in H2’24 vs. H1’24

View on SEC.gov

1052 earnings releases filed in the last 30 days. Browse all earnings releases →

Source: SEC EDGAR

accession 0001728205-24-000058

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.